Team Nightingale has been chosen as one of the official MIT Solvers in an event held at the United Nations HQ in New York. Nightingale presented their blood testing re-invention and was chosen as one of the winners amongst 15 finalists.
Solve is an initiative of the Massachusetts Institute of Technology (MIT) that identifies and supports lasting solutions to the world's most pressing challenges. The community brings together technologists, social entrepreneurs, business leaders, policymakers, researchers, and other change agents to implement solutions to specific, actionable challenges, including chronic diseases.
"Representing Nightingale's team and technology at the UN was a unique opportunity. Being selected as one of the MIT Solvers greatly accelerates our journey towards preventive healthcare in chronic diseases. We are looking forward to working together with the global Solvers community to make a concrete difference in the world", says Teemu Suna CEO and Co-founder of Nightingale.
Official Solvers continue to work with the global Solve community to implement their solutions, and will take part in the Solve at MIT event in Boston, Massachusetts in May.
Team Nightingale sends out a big thank you for all the support and votes!
Our latest health headlines delivered to your inbox.